Scientists in Australia are embarking on an extensive study aimed at understanding anxiety disorders, which affect approximately one in six Australians. This project, known as the QIMR Berghofer Living with Anxiety (LwA) study, seeks to uncover the genetic factors associated with anxiety, with the ambition of enhancing diagnosis, management, and treatment options for those affected.
To achieve this, researchers are actively seeking around 5,000 adult participants who have either been diagnosed with or received treatment for an anxiety disorder. The study aims to establish a clearer link between genetics and anxiety, which could pave the way for more targeted and effective treatments.
Anxiety is commonly addressed through psychological therapies, but medications, notably antidepressants, are also prevalent in treatment regimens. Unfortunately, many individuals experience significant side effects from these medications, including reduced appetite, sleep disturbances, and diminished libido.
The research team has expressed a keen interest in precision medicine, where genetic insights obtained from a simple saliva sample can be used to tailor medications specifically suited to individual needs. Professor Nick Martin from QIMR Berghofer highlighted that participants will be required to complete an online questionnaire and provide a saliva sample for analysis.
By harnessing genetic information, the research aims to lead to improved treatment outcomes, offering hope for those struggling with anxiety disorders. Professor Martin remains optimistic that this study will contribute to discovering more effective solutions for anxiety.